drugset / Trial / NCT01527123

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

NCT01527123 ↗

Phase 1 Completed 12 enrolled GlaxoSmithKline
NaSingle-groupOpen-labelBasic science

Summary

This is a Phase 1, single-center, open-label study to evaluate the pharmacokinetics of the BPO metabolites benzoic acid and hippuric acid with 7-day repeat application of GSK2585823 in subjects with acne vulgaris

Timeline

Start
2012-02-28
Primary completion
2012-06-01
Completion
2012-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK2585823 Unknown 1 % Topical
Subject GSK2585823 Unknown 3 % Topical

Indications